Drugs / Mesalamin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01059344 | Nov 2009 → Jul 2011 | ulcerative colitis | Tillotts Pharma AG | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mesalamin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01059344 ↗ |